News
Mo Salah's signed shirt from the club’s title-clinching win is just one of the shirts up for grabs in the international auction, which is being held on leading auction platform MatchWornShirt ...
Believe it or not, your shirt can have an impact on your golf game. If it’s soft, light and breathable, you won’t even think about it. But if it’s heavy, hot and tight, you’ll spend more ...
“Our PD-1 inhibitor Libtayo is the standard of care in advanced cutaneous squamous cell carcinoma, and in clinical trials, our investigational BCMAxCD3 bispecific antibody linvoseltamab has ...
“Our PD-1 inhibitor Libtayo is the standard of care in advanced cutaneous squamous cell carcinoma, and in clinical trials, our investigational BCMAxCD3 bispecific antibody linvoseltamab has ...
Key topics include results from the Phase 3 trial of Libtayo for high-risk cutaneous squamous cell carcinoma and data on linvoseltamab for relapsed or refractory multiple myeloma. Other research ...
“Our PD-1 inhibitor Libtayo is the standard of care in advanced cutaneous squamous cell carcinoma, and in clinical trials, our investigational BCMAxCD3 bispecific antibody linvoseltamab has ...
TEMPE, AZ (AZFamily) — A Tempe bar that was the scene of nearly 200 underage drinking arrests last week is now memorializing the raid with a controversial t-shirt. They’re comparing it to 9/11.
DAMAC Properties will be Chelsea's front-of-shirt sponsor for the rest of the season, the Premier League club confirmed on Wednesday. Chelsea have spent the majority of the 2024-25 campaign with a ...
CHELSEA have finally found a new shirt sponsor... which will be worn for the last few matches of the season. The Blues have spent the entirety of the campaign without a logo on the front of their kit.
She wore a blue cuffed linen shirt from one of her favourite affordable brands. Kate's linen shirt is from Boden and retails at £98, but using the code PQ4D, you can snap it up with 15% off for ...
Regeneron’s bispecific antibody linvoseltamab has received conditional approval from the European Commission (EC) for use in relapsed or refractory multiple myeloma. The decision comes just eight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results